Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Honeywell's UOP and QP to Jointly Develop Natural Gas Treating Technology

Published: Tuesday, February 04, 2014
Last Updated: Tuesday, February 04, 2014
Bookmark and Share
Agreement signed by the two companies is aimed at developing new technologies to lower the cost of treating natural gas for LNG production.

UOP LLC, a Honeywell company, has announced that it has signed a joint research and development agreement with Qatar Petroleum (QP) to develop new ways to cost effectively treat natural gas for the production of Liquefied Natural Gas, or LNG.

Under the agreement, the two companies will work together to develop more efficient technologies to remove contaminants from natural gas, so that it can be liquefied for transportation by ship and other means.

The agreement was signed at QP headquarters by His Excellency Dr. Mohammed bin Saleh Al-Sada, Minister of Energy and Industry and Chairman of QP, and UOP President and CEO Dr. Rajeev Gautam.

Honeywell's UOP is a leader in natural gas treating technologies, which are currently used in QP's LNG and gas processing facilities. QP's joint venture companies, Qatargas and RasGas, have a combined LNG production capacity of 77 million tonnes per annum (mta), making Qatar the world's largest producer and exporter of LNG.

H.E. Dr. Al-Sada said the agreement is an important milestone in Qatar's gas industry. "Qatar is constantly working to facilitate the optimum development of its hydrocarbon resources, and this agreement is another step in that direction," said H.E. Dr. Al-Sada. "Developing more efficient technologies to remove contaminants from natural gas will help boost Qatar's reputation as a safe, reliable supplier of natural gas as well as high-quality products."

Dr. Gautam said, "Global natural gas demand is growing rapidly and LNG production is critical to meeting the needs of regions not served by pipelines and to enable global trade. Qatar Petroleum is a recognized leader in the production of LNG for world markets, and we look forward to extending our long-standing partnership to develop technology in this important field."

UOP's separation technology and equipment remove contaminants such as sulfur, water and carbon dioxide from natural gas in order to meet rigorous product specifications and requirements for downstream transmission and liquefaction equipment.

In liquefied form, natural gas can be easily and efficiently transported to markets around the world, where it is used for a wide variety of energy applications.

Honeywell's UOP Gas Processing and Hydrogen business unit offers technology, equipment and materials to treat and process natural gas, as well as to purify the hydrogen used in refineries. Its gas technologies extract water, mercury, sulfur, carbon dioxide and other contaminants from raw natural gas.

UOP also offers technologies to recover natural gas liquids (NGLs). The business has supplied technology to more than 3,600 individual process units for gas processing in a broad range of applications through the world.

UOP has increased its offerings in natural gas in recent years. Earlier this year, it launched UOP Separex Flux+ and Select membrane elements to remove contaminants such as acid gas and water from natural gas. In 2012, the company purchased a majority stake in Thomas Russell Co., which offers technologies and modularized packaged plants enabling shale and conventional natural gas producers to remove contaminants from natural gas and recover high-value NGLs used for petrochemicals and fuels. Thomas Russell products are now part of the UOP Russell line. UOP also has marketing alliances with Twister B.V., and Ortloff Engineers, Ltd. for natural gas separation technology to recover NGLs.

Last year, QP and UOP collaborated to establish the first Engineering Design Seminar program in the Middle East to meet the growing demand for highly-trained engineers who specialize in refinery process units and equipment.

QP is a state-owned public corporation established by Emiri Decree No. 10 in 1974. It is responsible for all phases of the oil and gas industry in the State of Qatar.

The principal activities of QP, its subsidiaries and joint ventures are the exploration, production, local and international sale of crude oil, natural gas and gas liquids, refined products, synthetic fuels, petrochemicals, fuel additives, fertilizers, liquefied natural gas (LNG), steel and aluminium.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Michigan Researchers Use Raman Spectroscopy
inVia confocal Raman microscope used in the study of various childhood diseases.
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos